Reported Reactions

Devices › Implant, endosseous, root-form

Device brand name · Endosseous dental implant

AXIOM IMPLANT ?4.0 x 8.0: medical device reports filed with FDA

2,276 reports name it, 2021–2026. Manufacturer given most often on reports: Anthogyr. Product code DZE.

2,276
device reports naming the brand
0% of all MAUDE reports · about 421 a year
416
reports, 12 months to August 2026
382 in the 12 months before
0%
classified as malfunction
0.8% across the product code
0%
classified as death, as reported
0 reports · not verified by FDA

2,276 medical device reports received by FDA name the brand "AXIOM IMPLANT ?4.0 x 8.0" (endosseous dental implant); the manufacturer given most often on reports is Anthogyr; received from February 2021 to August 2026. Brand names are as the reporter or manufacturer wrote them, so one product can appear under several spellings.

416 reports arrived in the 12 months to August 2026, close to the 382 of the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (100%); across all implant, endosseous, root-form reports (product code DZE) death is recorded in 0% and malfunction in 0.8%. Event type is the reporter's classification of the report, not a verified outcome.

The device problems coded most often are failure to osseointegrate (78.9%), loss of osseointegration (19.7%) and fracture (0.9%). The patient problems coded most often are fibrosis, pain and inflammation. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Reports by month, five years

051101Sep 2021: 13Oct 2021: 17Nov 2021: 23Dec 2021: 282022Jan 2022: 101Feb 2022: 34Mar 2022: 34Apr 2022: 17May 2022: 22Jun 2022: 43Jul 2022: 36Aug 2022: 19Sep 2022: 32Oct 2022: 43Nov 2022: 36Dec 2022: 422023Jan 2023: 21Feb 2023: 17Mar 2023: 22Apr 2023: 19May 2023: 31Jun 2023: 57Jul 2023: 64Aug 2023: 41Sep 2023: 69Oct 2023: 41Nov 2023: 43Dec 2023: 442024Jan 2024: 32Feb 2024: 37Mar 2024: 34Apr 2024: 28May 2024: 32Jun 2024: 17Jul 2024: 26Aug 2024: 34Sep 2024: 34Oct 2024: 19Nov 2024: 20Dec 2024: 342025Jan 2025: 21Feb 2025: 27Mar 2025: 42Apr 2025: 15May 2025: 0Jun 2025: 99Jul 2025: 25Aug 2025: 46Sep 2025: 30Oct 2025: 31Nov 2025: 38Dec 2025: 372026Jan 2026: 38Feb 2026: 28Mar 2026: 38Apr 2026: 46May 2026: 36Jun 2026: 29Jul 2026: 30Aug 2026: 35

Reports by the month FDA received them. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.

By year received

02354692021: 31020212022: 45920222023: 46920232024: 34720242025: 41120252026: 2802026

Event type and report source

Event type, as classified on the report

Death0%0
Injury100%2,276
Malfunction0%0
Other0%0
Not given0%0

Who filed the report

Manufacturer report100%2,276
Voluntary report0%0
User facility report0%0
Distributor report0%0
Not given0%0

Grey bar: all 3,924,241 reports carrying product code DZE. Event type is the filer's classification and is not verified by FDA.

Device problems coded

Device problem (FDA code)ReportsShareShare across product code
Failure to osseointegrate1,79578.9%62.8%
Loss of osseointegration44919.7%22.4%
Fracturea broken bone210.9%1.6%
Difficult to insertthe device was hard to insert20.1%0.4%
Separation failure10%0.1%

FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.

Patient problems coded

Patient problem (FDA code)ReportsShare
Fibrosis35515.6%
Painpain, site not specified2199.6%
Inflammationinflammation1345.9%
Swelling/ edema1175.1%
Hemorrhage/blood loss/bleeding562.5%
Fistula552.4%
Abscessa collection of pus190.8%
Numbnessnumbness190.8%
Hypersensitivity/allergic reaction170.7%
Hyperresponsive to stimuli160.7%

Patient problem codes are present mainly in reports filed since 2019 and are often blank.

In context

MeasureAXIOM IMPLANT ?4.0 x 8.0Product code DZEAll MAUDE reports
Reports2,2763,924,24126,136,888
Share of that pool—0.1%0%
Classified as death, per 1,000 reports009
Classified as injury100%99.2%36.2%
Classified as malfunction0%0.8%62.3%
Filed by the manufacturer100%77.7%94.9%

Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Other brands with product code DZE

BrandReportsLatest 12 monthsClassified as death
Biohorizons Dental Implant58,73200%
BioHorizons Inc.57,02025,5360%
NobelActive Internal RP 4.3x10mm49,0989,5280%
BLT ?4.1mm RC, SLA? 10mm, TiZr, Loxim45,6509,6770%
NobelParallel CC RP 4.3x10mm44,2699,3180%
BLT ?4.1mm RC, SLActive? 10mm, TiZr, NTP41,6727,5310%
Unknown Implant39,9671,4540%
NobelReplace CC RP 4.3x10mm35,9468,1660%
NobelReplace CC PMC RP 4.3x10mm34,4478,6900%
NobelActive Internal RP 4.3x11.5mm33,1175,7040%
BLT ?3.3mm NC, SLA? 10mm, TiZr, Loxim28,6485,6950%
BLT ?4.1mm RC, SLA? 10mm, Ti, Loxim26,7248,4810%
BLT ?3.3mm NC, SLActive? 10mm, TiZr, NTP26,5404,6800%
NobelActive Internal RP 4.3x13mm25,5563,7640%
BLT ?4.1mm RC, SLA? 8mm, TiZr, Loxim24,7725,9780%

Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."

Questions about AXIOM IMPLANT ?4.0 x 8.0 reports

How many FDA reports name AXIOM IMPLANT ?4.0 x 8.0?

2,276 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 416 in the latest 12 months.

What kinds of events are reported?

injury (100%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.

What device problems are coded?

failure to osseointegrate (78.9%), loss of osseointegration (19.7%), fracture (0.9%), difficult to insert (0.1%) and separation failure (0%). These are FDA's device problem codes as entered on the report.

Who files these reports?

manufacturer reports (100%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.

Do these reports show that AXIOM IMPLANT ?4.0 x 8.0 was at fault?

No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."

How do I report a problem with a medical device?

Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.

Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.

Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.